Back

Deciphering the Caffeine-Specific Neuroprotective Axis: Comparative Docking and Pharmacokinetic Evaluation of the Coffee Phytocomplex

Ragazzi, E.; Zagotto, G.; Sartore, G.

2026-05-08 pharmacology and toxicology
10.64898/2026.05.05.723029 bioRxiv
Show abstract

BackgroundEpidemiological studies consistently report inverse associations between caffeinated coffee consumption and dementia risk. However, the molecular mechanisms linking coffee-derived phytochemicals to neuroprotection remain only partially understood. ObjectiveTo evaluate, through integrated in silico pharmacology, the relative contribution of adenosine receptor modulation versus direct amyloidogenic enzyme and kinase inhibition in mediating the putative neuroprotective effects of major coffee constituents. MethodsMolecular docking analyses were conducted for caffeine, paraxanthine, chlorogenic acid, trigonelline, cafestol, and kahweol against adenosine A2A and A1 receptors (A2AR, A1R), {beta}-secretase 1 (BACE1), glycogen synthase kinase-3{beta} (GSK-3{beta}), and NLRP3 inflammasome components. Docking was performed using the CB-Dock2 platform. Binding affinities, interaction patterns, and ligand efficiency metrics were assessed. Blood-brain barrier permeability and ADMET properties were predicted using pkCSM. ResultsCaffeine and paraxanthine demonstrated structurally coherent binding within the orthosteric pockets of A2AR and A1R, supported by favorable predicted blood-brain barrier penetration and high unbound fractions. Ligand efficiency analysis identified adenosine receptors as the most pharmacologically plausible targets for small xanthine derivatives. Although larger phytochemicals exhibited stronger absolute docking scores at BACE1, GSK-3{beta}, and NLRP3, predicted pharmacokinetic constraints suggest a small biological effect due to a limited central exposure. ConclusionsThese findings support an adenosine receptor-centered mechanism as the dominant molecular axis linking caffeinated coffee consumption to reduced dementia risk, favoring neuroinflammatory and signaling modulation over direct enzymatic inhibition. Experimental validation is warranted to confirm translational relevance. GRAPHICAL ABSTRACT O_FIG O_LINKSMALLFIG WIDTH=193 HEIGHT=200 SRC="FIGDIR/small/723029v1_ufig1.gif" ALT="Figure 1"> View larger version (38K): org.highwire.dtl.DTLVardef@1a02629org.highwire.dtl.DTLVardef@129890dorg.highwire.dtl.DTLVardef@1e4c05corg.highwire.dtl.DTLVardef@110ec7a_HPS_FORMAT_FIGEXP M_FIG C_FIG

Matching journals

The top 11 journals account for 50% of the predicted probability mass.

1
Frontiers in Pharmacology
100 papers in training set
Top 0.2%
10.2%
2
Alzheimer's Research & Therapy
52 papers in training set
Top 0.1%
9.3%
3
PLOS ONE
4510 papers in training set
Top 21%
8.5%
4
Science of The Total Environment
179 papers in training set
Top 2%
4.4%
5
The Journal of Prevention of Alzheimer's Disease
10 papers in training set
Top 0.1%
3.7%
6
Scientific Reports
3102 papers in training set
Top 39%
3.3%
7
Frontiers in Nutrition
23 papers in training set
Top 0.5%
2.6%
8
ACS Chemical Neuroscience
60 papers in training set
Top 0.7%
2.6%
9
Environment International
42 papers in training set
Top 0.6%
2.1%
10
ACS Pharmacology & Translational Science
40 papers in training set
Top 0.3%
2.1%
11
Biomedicine & Pharmacotherapy
43 papers in training set
Top 0.3%
1.9%
50% of probability mass above
12
Food & Function
12 papers in training set
Top 0.2%
1.9%
13
ACS Omega
90 papers in training set
Top 1%
1.8%
14
Journal of Translational Medicine
46 papers in training set
Top 0.9%
1.7%
15
International Journal of Molecular Sciences
453 papers in training set
Top 7%
1.7%
16
Journal of Agricultural and Food Chemistry
14 papers in training set
Top 0.6%
1.7%
17
International Journal of Environmental Research and Public Health
124 papers in training set
Top 4%
1.7%
18
Computational and Structural Biotechnology Journal
216 papers in training set
Top 5%
1.5%
19
Pharmaceuticals
33 papers in training set
Top 1.0%
1.2%
20
Journal of Psychopharmacology
14 papers in training set
Top 0.4%
1.2%
21
Molecules
37 papers in training set
Top 1%
1.0%
22
Food Chemistry
12 papers in training set
Top 0.3%
1.0%
23
Clinical and Translational Science
21 papers in training set
Top 0.7%
1.0%
24
eBioMedicine
130 papers in training set
Top 3%
0.9%
25
British Journal of Pharmacology
34 papers in training set
Top 0.4%
0.9%
26
Journal of Alzheimer’s Disease
39 papers in training set
Top 0.9%
0.9%
27
npj Aging
15 papers in training set
Top 0.8%
0.9%
28
Journal of Medicinal Chemistry
68 papers in training set
Top 1%
0.9%
29
Frontiers in Psychiatry
83 papers in training set
Top 3%
0.8%
30
Neurotherapeutics
11 papers in training set
Top 0.5%
0.8%